+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cholbam"

Cholbam - API Insight, 2022 - Product Thumbnail Image

Cholbam - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Cholbam is a market of drugs used to treat liver and kidney disorders. It is composed of medications that are used to treat a variety of conditions, including hepatitis, cirrhosis, and kidney failure. These drugs are used to reduce inflammation, improve liver and kidney function, and reduce the risk of complications. Cholbam is a combination of two drugs, cholic acid and bile acid, which are used to treat a variety of liver and kidney disorders. The drugs are available in both oral and injectable forms. Cholbam is a relatively new market, but it is growing rapidly. It is becoming increasingly popular as a treatment option for liver and kidney disorders due to its effectiveness and safety. Companies in the Cholbam market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more